<DOC>
	<DOCNO>NCT00003375</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether radiation therapy combine chemotherapy effective radiation therapy alone treat patient low-grade glioma . PURPOSE : Phase II/III trial evaluate observation compare effectiveness radiation therapy without combination chemotherapy treat patient low-grade glioma .</brief_summary>
	<brief_title>Observation Radiation Therapy With Without Combination Chemotherapy Treating Patients With Low-Grade Glioma</brief_title>
	<detailed_description>OBJECTIVES : - Identify overall survival low-risk adult patient supratentorial low-grade glioma observe postoperatively . - Compare overall survival high-risk adult patient supratentorial low-grade glioma receive postoperative external beam radiotherapy without procarbazine , lomustine , vincristine ( PCV ) chemotherapy . - Compare toxic effect postoperative radiotherapy without PCV chemotherapy patient unfavorable low-grade glioma . OUTLINE : This randomize study . Patients stratify accord tumor subtype ( astrocytoma [ mixed-astro dominant equal astro/oligo mix ] v oligodendroglioma [ mixed-oligo dominant ] ) , age ( young 40 v least 40 ) , Karnofsky performance status ( 60-80 % vs 90-100 % ) , contrast enhancement preoperative scan ( present v absent ) . Patients low-risk disease ( young 40 year old whose tumor surgically remove ) assign arm I . Patients high-risk disease ( least 40 year old incomplete tumor removal ) randomize arm II III . - Arm I ( low-risk patient ) : Patients observe . Patients may receive treatment tumor recurs . - Arm II ( high-risk patient ) : Patients receive daily external beam radiotherapy 5 day week 6 week . - Arm III ( high-risk patient ) : Patients receive radiotherapy arm II follow chemotherapy 1 month later . Chemotherapy consist oral lomustine day 1 , vincristine IV day 8 29 , oral procarbazine day 8-21 . Each course chemotherapy last 8 week . Patients may receive 6 course chemotherapy . Patients follow every 4 month 1 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : Approximately 252 patient accrue within 5.25 year .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Lomustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unifocal multifocal supratentorial WHO grade II astrocytoma ( diffuse fibrillary , protoplasmic , gemistocytic ) , oligodendroglioma , oligoastrocytoma Patients neurofibromatosis eligible No lowgrade histology , include : Pilocytic astrocytoma Subependymal giant cell astrocytoma tuberous sclerosis Subependymoma Pleomorphic xanthoastrocytoma Presence neuronal element ganglioglioma Dysneuroembryoplastic epithelial tumor No presence highgrade glioma , include : Anaplastic astrocytoma Glioblastoma multiforme Anaplastic oligodendroglioma Anaplastic oligoastrocytoma No tumor nonsupratentorial location include optic chiasm , optic nerve ( ) , pons , medulla , cerebellum , spinal cord No evidence spread spinal meninges noncontiguous cranial meninges ( i.e. , leptomeningeal gliomatosis ) No gliomatosis cerebri PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Hematopoietic : For highrisk patient : Granulocyte count least 1,500/mm^3 Platelet count normal Hepatic : Bilirubin great 2 time normal SGOT SGPT great 4 time normal Alkaline phosphatase great 2 time normal Renal : Creatinine great 2 time normal Pulmonary : No chronic lung disease ( unless DLCO least 60 % ) Neurological : Neurologic function score great 3 Other : Not pregnant nursing Fertile patient must use effective contraception No malignancy within past 5 year except carcinoma situ cervix nonmelanoma skin cancer No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy head neck ( unless brain clearly exclude , radiotherapy localized vocal cord cancer ) Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
</DOC>